Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission

Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission

Background/Aims Serum leucine-rich alpha-2 glycoprotein (LRG) is a potential biomarker of Crohn’s disease (CD). This study aimed to evaluate the usefulness of LRG in predicting clinical relapse in patients in remission with CD. Methods This retrospective observational study assessed the relationship...

Full description

Saved in:
Bibliographic Details
Main Authors: Naohiro Nakamura, Yusuke Honzawa, Yuka Ito, Yasuki Sano, Naoto Yagi, Sanshiro Kobayashi, Mamiko Aoi, Takashi Tomiyama, Tomomitsu Tahara, Norimasa Fukata, Toshiro Fukui, Makoto Naganuma
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2025-04-01
Series:Intestinal Research
Subjects:
crohn disease
leucine-rich alpha-2 glycoprotein
biomarkers
Online Access:http://irjournal.org/upload/pdf/ir-2024-00042.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items